Overview

Update
Total Equity Funding
$38.26M in 6 Rounds from 9 Investors
Most Recent Funding
$269k Venture on April 6, 2012
Headquarters:
New Haven, Connecticut
Description:
BioRelix is engaged in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases.
Founders:
, , ,
Categories:
Pharmaceutical, Biopharma, Biotechnology
Website:
http://www.biorelix.com

Company Details

Update

BioRelix, Inc., a biopharmaceutical company, engages in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases in the United States. It develops a portfolio of riboswitch-based therapeutic agents to overcome the lethal and devastating causes of bacterial infections. The company was founded in 2005 and is based in New Haven, Connecticut.

Funding Rounds (7) - $40.66M

Update
DateAmount / RoundValuationLead InvestorInvestors
Apr, 2012$269k / Venture1
Mar, 2012$2.56M / Venture4
Jan, 2012$500k / Venture0
Sep, 2011$3.6M / Venture0
Dec, 2010$2.4M / Debt Financing0
Jan, 2010$5.54M / Series A0
Jun, 2007$25.8M / Series A6

Current Team (4)

Update

News (10)

Update
DateNews
Dec 2, 2013SEC - SEC FORM D/A
Apr 6, 2012FinSMEs - FinSMEs
Mar 22, 2012(see Boston Tech Flash) - BioRelix raises 25800000 in venture round
Mar 22, 2012(see Boston Tech Flash) - BioRelix raises 2560000 in unknown round
Jan 18, 2012Boston Tech Flash - Conn. antibiotics maker BioRelix rounds up $500K - Boston Business Journal
Sep 6, 2011Boston Tech Flash - BioRelix lands $3.6M to treat infectious diseases - Boston Business Journal
Sep 6, 2011Xconomy - BioRelix Secures $3,644,085 New Funding
Dec 23, 2010(see Boston Tech Flash) - BioRelix raises 2400000 in debt_financing round

Offices/Locations (1)

Update
  • Headquarters

    5 Science Park

    401 Winchester Avenue

    New Haven, Connecticut 06511

    United States

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos